Madely Health Headlines Commentary for December 14, 2009
Source:
Drug Combo boosts advanced breast cancer survival
Comment:
This approach to treatment applies only to HER-2 breast cancers that according to the article represents 1 in 4 breast cancers.
Related articles:
- Paxil interferes with tamoxifen’s efficacy combating breast cancer/Sunday House Call returns to the airwaves
- Estrogen-sensitive breast cancer risk reduction study finds two drugs that work but have trade-offs
- New evidence reevaluates breast cancer screening
- Promising breast cancer treatment needs supporting studies
- More genes linked to breast cancer risk
